Exploring the Immunological Shield Hypothesis: A Population-Based Exploration of Phenotypic Divergence Between Lipedema and Celiac Disease Autoimmunity
O lipedema se caracteriza por acúmulo desproporcional de gordura glúteo-femoral, um tecido com propriedades anti-inflamatórias. Os autores levantam a hipótese de que esse fenótipo poderia conferir proteção contra autoimunidade mediada por Th1 — a chamada hipótese do escudo imunológico.
A análise é transversal, com 3.833 mulheres do NHANES 2011-2014. A doença celíaca foi definida por sorologia estrita (tTG-IgA+ e EMA-IgA+), resultando em 11 casos (prevalência ponderada de 0,56%); o fenótipo lipedema foi definido por razão de gordura perna/tronco acima do percentil 90 na densitometria (DXA).
Mulheres com doença celíaca apresentaram 7,4% menos gordura ginoide (39,5% contra 42,6%, p = 0,0007), diferença que se manteve nos estratos de sobrepeso e obesidade. Na direção oposta, o fenótipo lipedema mostrou melhor saúde metabólica: HOMA-IR 44,2% menor (p < 0,001) e relação neutrófilo/linfócito 7,6% menor (p = 0,012). Os autores são explícitos quanto ao alcance: a análise é exploratória e limitada pelo pequeno número de casos celíacos, produzindo achados compatíveis com a hipótese, mas não confirmatórios.
Referência completa
Amato AC, Amato JL, Benitti D. Exploring the immunological shield hypothesis: a population-based exploration of phenotypic divergence between lipedema and celiac disease autoimmunity. Cureus. 2026;18(2):e104222. doi:10.7759/cureus.104222
Abstract
Background Lipedema is characterized by disproportionate gluteofemoral adiposity with anti-inflammatory properties. We hypothesized that this phenotype may confer immunological protection against T-helper 1 (Th1)-mediated autoimmunity (“Immunological Shield Hypothesis”). Objective The objective of this study is to explore whether women with a dual-energy X-ray absorptiometry (DXA)-defined lipedema-like phenotype, characterized by disproportionate gluteofemoral fat accumulation, exhibit distinct immunometabolic profiles and lower prevalence of celiac disease (CD) autoimmunity in a nationally representative sample. Methods The cross-sectional analysis included 3,833 women from the National Health and Nutrition Examination Survey (NHANES) 2011-2014. Celiac disease (n=11, 0.56% weighted prevalence) was defined by strict serology (tissue transglutaminase {tTG}-IgA+/endomysial antibody {EMA}-IgA+); lipedema phenotype was defined as leg-to-trunk fat ratio of >90th percentile via DXA. Results Women with celiac disease exhibited 7.4% lower gynoid fat (39.5% versus 42.6%, p=0.0007), persisting in overweight/obese strata. Conversely, the lipedema phenotype demonstrated superior metabolic health: 44.2% lower homeostatic model assessment of insulin resistance (HOMA-IR) (p<0.001) and 7.6% lower neutrophil-to-lymphocyte ratio (NLR) (p=0.012). Conclusions This exploratory population-based analysis identifies phenotypic divergence in fat distribution between the DXA-defined lipedema phenotype and celiac disease autoimmunity, yielding observations consistent with, but not confirmatory of, the “Immunological Shield Hypothesis.” While limited by the small number of celiac cases (n=11), a sample size insufficient to detect prevalence differences for a ~7%-9% phenotype, for which approximately 225-600 celiac cases would be required, the observed differences in gynoid adiposity (7.4% reduction, p=0.0007) and the favorable metabolic profile of the lipedema phenotype (44.2% lower HOMA-IR and 7.6% lower NLR) suggest biological plausibility warranting validation in larger, targeted cohorts. These findings motivate targeted studies to evaluate whether dietary exposures, including gluten-related immune activation, interact with gluteofemoral adipose biology in lipedema.
Original abstract as published in Cureus.